Search

Your search keyword '"Suchard, Marc A."' showing total 60 results

Search Constraints

Start Over You searched for: Author "Suchard, Marc A." Remove constraint Author: "Suchard, Marc A." Publisher cold spring harbor laboratory Remove constraint Publisher: cold spring harbor laboratory
60 results on '"Suchard, Marc A."'

Search Results

3. How fast are viruses spreading in the wild?

5. Dispersal history of SARS-CoV-2 in Galicia, Spain

6. Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study

7. Routes of importation and spatial dynamics of SARS-CoV-2 variants during localised interventions in Chile

8. COVID-19 pandemic re-shaped the global dispersal of seasonal influenza viruses

10. Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic

12. Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics

13. Putative APOBEC3 deaminase editing in MPXV as evidence for sustained human transmission since at least 2016

14. Multinational Patterns of Second-line Anti-hyperglycemic Drug Initiation Across Cardiovascular Risk Groups: A Federated Pharmacoepidemiologic Evaluation in LEGEND-T2DM

15. Climate and land-use shape the spread of zoonotic yellow fever virus

16. Best of intent, worst of both worlds: why sequentially combining epidemiological designs does not improve signal detection in vaccine safety surveillance

17. Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States

18. Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions

20. Total virome characterizations of game animals in China reveals a spectrum of emerging viral pathogens

22. Predicting the evolution of Lassa Virus endemic area and population at risk over the next decades

24. Vaccine safety surveillance using routinely collected healthcare data – An empirical evaluation of epidemiological designs

25. Bias, precision and timeliness of historical (background) rate comparison methods for vaccine safety monitoring: an empirical multi-database analysis

26. Characterizing Dual Combination Therapy Use in Treatment Escalation of Hypertension: Real-World Evidence from Multinational Cohorts

27. Empirical evaluation of the sensitivity of background incidence rate characterization for adverse events across an international observational data network

28. Archival influenza virus genomes from Europe reveal genomic and phenotypic variability during the 1918 pandemic

30. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study

31. A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data

32. Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study

33. Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil

34. Emergence of an early SARS-CoV-2 epidemic in the United States

35. Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

37. An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza

39. Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States

40. Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis

41. Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study

42. Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States

43. “Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis”

44. Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America

45. Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study

46. Snapshot of the evolution and mutation patterns of SARS-CoV-2

48. Accommodating individual travel history, global mobility, and unsampled diversity in phylogeography: a SARS-CoV-2 case study

49. Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets

50. Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study

Catalog

Books, media, physical & digital resources